Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
826 studies found for:    Open Studies | "HIV Infections"
Show Display Options
Rank Status Study
1 Recruiting Antiretroviral Therapy for Acute HIV Infection
Condition: Acute HIV Infection
Interventions: Drug: HAART;   Drug: Mega-HAART
2 Recruiting Traditional Complementary and Alternative Medicine (CAM) Therapy in the Treatment of HIV/AIDS
Condition: HIV Infections
Intervention: Drug: "Kallunk oxide (Immunotherapy) "
3 Not yet recruiting Modulating the Impact of Critical Events in Early HIV Infection: Effect of ART Initiation and Alcohol Use
Condition: HIV Infection
Interventions: Other: ART initiation at time of HIV diagnosis;   Other: ART at 24 weeks post-diagnosis
4 Recruiting A Prospective Cohort of Children With HIV Infection
Condition: HIV Infections
Interventions: Drug: Zidovudine, Stavudine, Didanosine, Lamivudine;   Drug: Nevirapine, Efavirenz;   Drug: LPV/r, Saquinavir, Indinavir, Ritonavir, Nelfinavir
5 Recruiting Feasibility and Interest of a HIV Quarterly Preventive Global Care in Men Who Have Sex With Men in Sub-Saharan Africa
Condition: HIV Infection
Intervention: Other: HIV quarterly global care
6 Not yet recruiting Impact of HIV Self-testing Among Female Sex Workers in Kampala, Uganda
Condition: HIV Infection
Intervention: Other: Oral HIV Self-Testing
7 Recruiting Zambian Peer-Educators for HIV Self-Testing Study
Condition: HIV Infection
Intervention: Other: Oral HIV Self-Testing
8 Recruiting AIDS 347: IL-6 Blockade in Treated HIV Infection
Condition: HIV Infections
Interventions: Drug: tocilizumab;   Drug: Placebo
9 Recruiting IMPAACT P1115: Very Early Intensive Treatment of HIV-Infected Infants to Achieve HIV Remission
Condition: HIV Infection
Intervention: Drug: Intensive ART regimen
10 Recruiting Analysis of Telmisartan Administered With Antiretroviral Therapy (ART) in Patients With Acute HIV Infection
Conditions: Acute HIV Infection;   HIV Infections
Intervention: Drug: Telmisartan
11 Not yet recruiting Co-adaptation Between Human Immunodeficiency Virus (HIV) and Cluster of Differentiation 8 (CD8) Cellular Immunity
Condition: HIV Infection
Intervention: Other: Non interventional study
12 Recruiting Safety and Virologic Effect of a Human Monoclonal Antibody (VRC01) Administered Intravenously to Adults During Early Acute HIV Infection
Condition: HIV Infections
Interventions: Biological: VRC01;   Biological: Placebo for VRC01;   Drug: Antiretroviral therapy (ART) (regimen will vary within countries and by patient)
13 Recruiting Safety and Therapeutic Efficacy of the VRC01 Antibody in Patients Who Initiated Antiretroviral Therapy During Early Acute HIV Infection
Condition: HIV Infections
Interventions: Biological: VRC01;   Biological: Placebo for VRC01
14 Recruiting Implementation of Nucleic Acid Amplification Testing Screening to Identify Acute and Early HIV Infection
Condition: Acute HIV Infection
Intervention: Other: Nucleic Acid Amplification Testing
15 Recruiting A Long-term Follow-up of the HIV-NAT Cohort
Condition: HIV Infections
Intervention:
16 Recruiting Neural Correlates of Working Memory Training for HIV Patients
Condition: HIV Infection
Intervention: Device: CogMedTM Training
17 Not yet recruiting Strategies to Improve the HIV Care Continuum Among Key Populations in India
Condition: HIV Infections
Interventions: Behavioral: Incentives;   Behavioral: Integrated Care Centers
18 Recruiting Metformin Immunotherapy in HIV Infection
Condition: HIV Infection
Intervention: Drug: Metformin
19 Recruiting Dolutegravir-based Dual Therapies in HIV-infected Patients With Virological Suppression
Condition: HIV Infection
Intervention: Other: Dolutegravir in a dual therapy regimen
20 Recruiting Safety and Immunogenicity of HIVAX in HIV-1 Infected Subjects
Condition: HIV Infections
Interventions: Biological: HIVAX;   Biological: saline solution;   Biological: Saline solution

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.